West Virginia University Logo

February 19, 2015


SAMHSA Prescription Drug Abuse Weekly Update
Issue 110  |  February 19, 2015
The Prevention of Prescription Drug Abuse in the Workplace (PAW) TA Center addresses prescription drug abuse—a growing public health problem with increasing burdens on workers, workplaces, and our economy. To subscribe colleagues, family members, or friends to this listserv sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA), please click here or send their e-mail addresses to paw@dsgonline.com.
Table of Content Featured Article Journal Articles and Reports Professional Education National News International News Northeast/Mid-Atlantic News South News Midwest News West News Other Resources Grant Announcements Take-Back Events and Drop Boxes Upcoming Conferences and Workshops


NHTSA Releases Two New Studies on Impaired Driving on U.S. Roads
National Highway Traffic Safety Administration
February 6, 2015

A National Highway Traffic Safety Administration (NHTSA) study conducted in Virginia Beach, Va., gathered data over a 20-month period from more than 3,000 drivers involved in crashes. Two controls for each crash-involved driver were randomly selected from traffic passing the crash location, driving in the same direction of travel, on the same day of the week and time of day 1 week later. Controlling for age, sex, and race/ethnicity, crash risk was unaffected by the presence of active marijuana in a driver's system. Also controlling for blood alcohol level, the odds ratio (OR) for a crash was identical for drivers with and without active marijuana (OR = 1.00). It appeared drivers' use of opioid analgesics or other sedatives might modestly elevate crash risk (OR around 1.2, but not significant).

NHTSA's 2014 Roadside Survey of Alcohol and Drug Use by Drivers found the number of drivers with alcohol in their systems declined by nearly one third since 2007, and by more than three fourths since the first Roadside Survey in 1973. In the 2014 survey, nearly one in four drivers tested positive for at least one drug that could affect safety. The number of weekend nighttime drivers with evidence of drugs in their systems climbed from 16 percent in 2007 to 20 percent in 2014. The number of drivers with marijuana in their systems almost doubled.

Read more:
Roadside Survey Executive Summary
Roadside Survey Fact Sheet

Journal Articles and Reports

T. Abrahamsson, M. Berglund, and A. Håkansson. 2015. "Non-Medical Prescription Drug Use (NMPDU) and Poor Quality of Life in the Swedish General Population." The American Journal on Addiction, doi:10.1111/ajad.12184.

A 2008–09 national household survey showed 4 percent of Swedes ages 15 to 64 reported past-year nonmedical use of prescription analgesics (examples all involved codeine combinations), and 2.2 percent reported past-year nonmedical use of prescription sedatives. The survey measured quality of life using the 12-question MANSA, which asks about satisfaction with life as a whole, work, financial situation, friendships, leisure activities, accommodations, personal safety, the people one lives with, sex life, family relations, and physical and mental health. Multivariate logistic regression showed odds of being in the lowest quartile of the quality-of-life distribution were 1.4 for analgesic users and 2.1 for sedative users. Poor health might have caused both the nonmedical use and poor quality of life. The survey response rate was 38 percent (22,095 responses).

Read more:

J. Elmer, M.J. Lynch, J. Kristan, P. Morgan, S.J. Gerstel, C.W. Callaway, and J.C. Rittenberger. 2015. "Recreational Drug Overdose–Related Cardiac Arrests: Break on Through to the Other Side." Resuscitation, doi:10.1016/j.resuscitation.2015.01.028.

Between 2009 and February 2014, among 591 patients admitted to a Pittsburgh trauma center after presenting with out-of-hospital cardiac arrest, 85 cases (14 percent) were overdose related. Overdose patients were significantly younger than others who arrested, had fewer medical comorbidities, were more likely to present with non-shockable rhythms, and had worse baseline neurological function. However, overall survival, neurological outcomes, and length of stay did not vary between groups. Overdose patients who survived to discharge had a significantly higher rate of favorable discharge dispositions (83 percent discharged to home or acute rehabilitation vs. 62 percent of non-overdose patients). The study excluded patients with cardiac arrests secondary to blunt or penetrating trauma, stroke, or subarachnoid hemorrhage.

Read more:

E. Evans, L. Li, J. Min, D. Huang, D. Urada, L. Liu, Y–I. Hser, and B. Nosyk. 2015. "Mortality Among Individuals Accessing Pharmacological Treatment for Opioid Dependence in California, 2006–2010." Addiction, doi:10.1111/add.12863.

Researchers checked National Death Index data for matches to the 32,322 people first admitted to publicly funded agonist treatment for opioid dependence in California between 2006 and 2010. They identified 1,031 deaths (3.2 percent) over a median follow-up of 2.6 years (interquartile range: 1.4–3.7 years). Individuals treated for opioid dependence had a standardized mortality ratio (SMR) of 4.5, relative to a standard life table. Mortality risk was higher when individuals were out-of-treatment (SMR 6.1) than in treatment (SMR 1.8) and during detoxification (SMR 2.4) rather than methadone maintenance treatment (SMR 1.8), especially in the 2 weeks post-treatment entry (SMR 5.5). Compared to out-of-treatment periods, all-cause mortality risk was lower with detoxification only (hazard ratio [HR] .21), detoxification plus methadone (HR 0.20), or methadone only (0.30).

Read more:

A. Shei, J. Bradford Rice, N.Y. Kirson, K. Bodnar, H.G. Birnbaum, P. Holly, and R. Ben–Joseph. 2015. "Sources of Prescription Opioids Among Diagnosed Opioid Abusers." Current Medical Research and Opinion, doi:10.1185/03007995.2015.1016607.

Researchers identified commercially insured patients ages 12 to 64 diagnosed with opioid abuse or dependence ("abuse") in OptumHealth medical and pharmacy claims data for 2006–12. They restricted analysis to abusers continuously eligible over an 18-month study period before and after the first abuse diagnosis (including in 2004–05 claims data). Of the 9,291 abusers meeting selection criteria, 80 percent had an opioid prescription prior to their first abuse diagnosis. Of the remainder, 51 percent had a family member with an opioid prescription before their first abuse diagnosis, compared with 24 percent of non-abusers.

Read more:

K. Wiese Simonsen, H.M.E. Edvardsen, G. Thelander, I. Ojanperä, S. Thordardottir, L.V. Andersen, P. Kriikku, V. Vindenes, D. Christoffersen, G.J.M. Delaveris, and J. Frost. 2015. "Fatal Poisoning in Drug Addicts in the Nordic Countries in 2012." Forensic Science International 248:172–180, doi:10.1016/j.forsciint.2015.01.003.

Comparing 2012 poisoning mortality data from the five Nordic countries—Denmark, Finland, Iceland, Norway, and Sweden—with data from 1991, 1997, 2002, and 2007 showed death rates were relatively stable. Opioids remained the major cause of death, but medicinal opioids largely replaced heroin. Methadone was involved in the most deaths in Denmark and Sweden; heroin/morphine was most involved in Norway; and buprenorphine was most involved in Finland. After 2012, prescription opiate deaths surged in Sweden. Polydrug use was the norm, with the median number of different drugs between four and five. Heroin/morphine, medicinal opioids, cocaine, amphetamines, benzodiazepines, and alcohol were the main drugs involved.

Read more:

S.M. Smith, F. Paillard, A. McKeown, L.B. Burke, R.R. Edwards, N.P. Katz, E.J. Papadopoulos, B.A. Rappaport, A. Slagle, E.C. Strain, A.D. Wasan, D.C. Turk, and R.H. Dworkin. 2015. "Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review." Journal of Pain, doi:10.1016/j.jpain.2015.01.009.

Researchers examined if any of the 16 published instruments assessing inappropriate use of opioid and non-opioid prescription medications met U.S. and European regulatory agencies' standards for outcome measures in clinical trials. None did. Most lacked documented content validity to evaluate current inappropriate medication use, included items that did not directly assess inappropriate use (e.g., questions about anger), or failed to capture information pertinent to inappropriate use events (e.g., intention, route of administration). Psychometric data across all instruments was limited in scope.

Read more:

X. Tao, R.A. Lavin, L Yuspeh, V. Weaver, and E. Bernacki. 2015. "The Association of the Use of Opioid and Psychotropic Medications with Workers' Compensation Claim Costs and Lost Work Time." Journal of Occupational and Environmental Medicine 57(2):196–201, doi:10.1097/JOM.0000000000000333.

Researchers analyzed data on one workers' compensation insurer's lost-time claimants injured in Louisiana between 1999 and 2002, with claims followed through 2009. Compared with claimants who were never prescribed opioids, odds of claim costs exceeding $100,000 by medications prescribed were 4.3 for short-acting opioid prescriptions only, 8.6 for long-acting opioids, 2.8 for hypnotics, 2.6 for antipsychotics, 1.6 for anti-anxiety agents, and 2.9 for antidepressants. These differences probably result from variances in injury severity, recovery, and psychological impact.

Read more:

S.D. Turner, T. Gomes, X. Camacho, Z. Yao, A. Guttmann, M.M. Mamdani, D.N. Juurlink, and I.A. Dhalla. 2015. "Neonatal Opioid Withdrawal and Antenatal Opioid Prescribing." CMAJ Open 3(1):E55–E61, doi:10.9778/cmajo.20140065.

Incidence of neonatal abstinence syndrome (NAS) in Ontario increased from 0.28 per 1,000 live births in 1992 to 4.29 per 1,000 live births in 2011. From 2007 to 2011, mothers of 927 infants with NAS were public drug plan beneficiaries. Of these, 67 percent had received an opioid prescription in the 100 days preceding delivery, including 53 percent who received methadone.

Read more:

M.D. Warren, A.M. Miller, J. Traylor, A. Bauer, and S.W. Patrick. 2015. "Implementation of a Statewide Surveillance System for Neonatal Abstinence Syndrome—Tennessee, 2013." Morbidity and Mortality Weekly Report 64(5):125–28.

In 2013, 1,101 cases of neonatal abstinence syndrome (NAS) were reported through Tennessee's surveillance system, but 39 were duplicates, and 141 lacked clinical signs consistent with NAS. A total of 921 cases (among 79,954 births) were reported in 2013. When surveillance system cases reported during a 6-month period were compared with counts from hospital discharge data, the surveillance system captured 88 percent of cases. In addition to clinical signs of NAS, 98 percent of cases had a positive maternal or neonatal drug screen or a history of maternal substance use. Male babies accounted for 58 percent of cases. The most commonly reported sources of exposure were supervised replacement therapy (methadone or buprenorphine, 46 percent), prescription substance obtained without a prescription (40 percent), and nonprescription substance (27 percent). When cases were analyzed using mutually exclusive categories of exposure source, 42 percent involved maternal use of prescribed drugs only; 22 percent involved prescribed and illicit/diverted drugs; and 33 percent involved illicit/diverted drugs only.

Read more:

Professional Education

S. Fogger and T.M. McGuinness. 2015. "Adolescents at Risk: Pain Pills to Heroin: Part II." Journal of Psychosocial Nursing and Mental Health Services 53(2):27–30, doi:10.3928/02793695-20150106-01.

Although treatment for substance use disorders has traditionally centered on total abstinence, opioid replacement therapy (ORT) is an option that saves lives and prevents overdose deaths. In the United States, ORT is based on two medicines: methadone and buprenorphine. Nursing implications and Web-based resources for teaching are presented.

Read more:

National News

Inspirion Delivery Technologies Announces FDA Acceptance of Morphabond™ ER (Morphine Sulfate Extended-Release) New Drug Application; Its Investigational Abuse-Deterrent, Extended-Release Opioid
PR Newswire
February 9, 2015

The Food and Drug Administration will review Inspirion Delivery Technologies' New Drug Application for MorphaBond™ ER, an extended-release, abuse-deterrent formulation of morphine.

Read more:

Markey Joins Senators to Reintroduce Bipartisan Bill to Reauthorize Program to Curb Prescription Drug Addiction
Ed Markey, United States Senator for Massachusetts
February 12, 2015

Senators Edward J. Markey, Jeanne Shaheen, Pat Toomey, Dick Durbin, and Jeff Sessions reintroduced bipartisan legislation to reauthorize the National All-Schedules Prescription Electronic Reporting program, which provides state grants to maintain, improve, and expand prescription drug monitoring programs.

Read more:

U.S. Schools Turn to New Programs to Warn Teens of Drug Risks
Laila Kearney, Reuters
February 9, 2015

New school-based prevention programs on prescription pain relievers use lengthy studies and interactive computer programs. They focus on the science of addiction instead of scare tactics. The programs contend they have developed more effective strategies, but have not performed evaluation beyond pre- and posttests. The hour-long Narcotics Overdose Prevention and Education (NOPE) program teaches students how to recognize symptoms of drug overdoses, emphasizes the importance of seeking medical attention for overdose victims, and tells teens prescription drugs are not safe for use other than under a doctor's orders. The Heroin Prevention Education program uses software based on the life of a recovering teen heroin addict who began abusing opioids after having his wisdom teeth pulled. Eventually, he turned to intravenous heroin use.

Read more:

NCCIH Working Group Recommends Large-Scale Collaborative Research into Pain Management
National Institutes of Health
February 11, 2015

A working group of the National Center for Complementary and Integrative Health's (NCCIH's) Advisory Council recommended the Center assess the feasibility of conducting larger-scale studies on nondrug approaches to pain management. The group suggested evaluating the impact of pain on patient function and quality of life as primary outcome measures, with changes in use of opioids and other drugs as a secondary outcome; evaluating an integrated package of nondrug treatments, an integrative model of care, or a holistic approach to care rather than focusing on individual complementary health approaches; focusing on patients in the early stages of chronic pain; leveraging natural experiments and existing resources whenever possible; and being pragmatic and embedded in the delivery of care.

Read more:

International News

Naloxone, Overdose-Reversal Drug, Gives Life Back to B.C. Addicts
Sara Harowitz, The Huffington Post British Columbia
February 10, 2015

The British Columbia Centre for Disease Control's Take Home Naloxone program has saved 162 people in the province since it began in summer 2012. The drug can be picked up at 62 sites across British Columbia, and users can undergo basic training. A free patient kit contains two vials, needles, and instructions. Naloxone must be prescribed by a doctor or nurse practitioner and can only be given to opioid users. Canadian naloxone initiatives have only reached British Columbia, Ontario, and Edmonton. B.C. police do not carry naloxone, but emergency medical workers administer the drug.

Read more:

Northeast/Mid-Atlantic News

Maine Could Lose Program That Alerts Doctors to Patients with Drug Arrests
Jen Lynds, The Bangor Daily News
February 9, 2015

Maine's Diversion Alert Program will be eliminated this year without new funding. The program helps healthcare providers identify patients who may be abusing or illegally distributing prescription drugs and who are at risk of overdosing. Each month, it distributes a list of individuals arrested or summoned for prescription or illegal drug–related crimes to prescribers, pharmacists, and law enforcement agencies registered to receive the alerts.

Read more:

After Kinney, Area Police Rethink Drug Drop Boxes
Elizabeth Murray, Burlington Free Press
February 8, 2015

Vermont's Winooski Police Department is reconsidering its 24-hour drug drop box policy following an alleged theft at the Colchester Police Department. Now someone must accompany the lieutenant when he empties the drop box. Drug take-back programs cited for exemplary accountability involve multiple officers and careful documentation.

Read more:

R.I. Police Grapple with Disposal of Unwanted Prescription Drugs
Lynn Arditi, Providence Journal
February 9, 2015

Rhode Island police departments are contemplating removing drug disposal boxes unless they can find a safe, cost-effective way to empty their contents. One option is to incinerate discarded prescription drugs that have piled up in collection boxes and evidence-storage rooms for nearly 5 months. But the state lacks a licensed incinerator. U.S. Attorney Peter Neronha suggested contacting Covanta Energy, which offers free disposal and incineration services for household pharmaceuticals collected by law enforcement agencies in Massachusetts, Connecticut, New York, and New Jersey.

Read more:

Malloy Wants Legislation Passed to Combat Prescription Abuse
Valley Gazette
February 11, 2015

Connecticut Governor Dannel Malloy will propose legislation to combat substance abuse and opioid overdoses in the state. The legislation would streamline prescription reporting, impose continuing education requirements for practitioners, and increase naloxone availability.

Read more:

Narcan Has Saved More Than 100 Lives Across New York
Lou Michel, The Buffalo News
February 11, 2015

More than 100 lives have been saved across New York since police started carrying Narcan® kits less than a year ago. The state's attorney general announced an agreement with Amphastar Pharmaceuticals to reduce and cap the drug's price.

Read more:

Firm Targets Fake Painkiller Prescriptions
Dan Adams, The Boston Globe
February 9, 2015

Imprivata Inc. of Massachusetts has developed Confirm ID, an electronic prescription system that could help deter opiate abuse. The software securely transmits sensitive information directly from doctors to pharmacies. It requires doctors to scan their fingerprints or use a one-time password. It keeps physicians' signatures and Drug Enforcement Administration registration numbers out of public view, while allowing healthcare professionals to track opiate prescriptions and detect potential overprescribers.

Read more:

As Heroin Abuse Rises, Harford Educators Say New Approaches Needed
Bryna Zumer, The Baltimore Sun
February 13, 2015

Police in Harford County, Md., have investigated 17 heroin overdoses in 6 weeks. Public school officials are incorporating the latest drug slang into their health education programs. They have shifted to making drug education part of general health education, instead of using evidence-based drug abuse prevention programs.

Read more:

South News

Lawmakers Pass Bill to Curb W.Va. Drug Overdoses
Eric Eyre, The Charleston Gazette
February 11, 2015

The West Virginia House of Delegates unanimously passed a bill allowing doctors to prescribe naloxone to drug users, family members, caregivers, and friends.

Read more:

House Unanimously Passes Bill to Help Fight Fatal Overdoses
Amy Friedenberger, The Roanoke Times
February 10, 2015

The Virginia House of Delegates passed a Good Samaritan bill, which now goes to the Senate. The legislation does not offer immunity for any crime that might have occurred surrounding the overdose. It only protects the person helping the overdose victim from prosecution for possession or intoxication.

Read more:

Sen. Baldwin Asks Department of Justice to Investigate Deaths, Drug Prescriptions at Tomah VA
Dana Ferguson, Star Tribune
February 13, 2015

Senator Tammy Baldwin wrote a letter to Attorney General Eric Holder asking the U.S. Department of Justice to investigate three deaths and reports of prescription drug abuse at the Tomah VA Medical Center in Virginia.

Read more:

Midwest News

Police Offer Parents Home Drug-Testing Kits
Emily Matesic, WBAY
February 10, 2015

The Town of Menasha Police Department in Wisconsin is offering free iCup home drug-test kits to parents. The 10-panel test can detect drugs such as marijuana, opiates, and ecstasy. In addition to the kits, parents will also be given a "Now What?" brochure on how to get help. (Includes video: 1:46 minutes)

Read more:

Families Free Receives Renewed Funding for Drug-Addicted Babies/Mothers Pilot Program
Kylie McGivern, WJHL
February 11, 2015

The Tennessee Department of Health renewed funding for Woven, a pilot program of the nonprofit organization Families Free. The program works with women who give birth to drug-exposed or addicted babies. It provides individual case management, alcohol and drug treatment, coordination of services with the Department of Children's Services, parenting education, and life skills. This year, pregnant women involved in Woven will be asked to taper off medications such as Suboxone, Subutex, and Klonopin within 30 days. In more than half of cases reported statewide last week, the mother was on "supervised replacement therapy." (Includes video: 4:02 minutes)

Read more:

Survey Shows Alcohol, Tobacco, Prescription Drug Use Among North Royalton 10-Graders Inching Upward
Bob Sandrick, Northwest Ohio Media Group
February 12, 2015

In a survey, 7 percent of 10th graders in North Royalton, Ohio, schools said they took prescription drugs in 2013. Among seventh graders, prescription drug use went from being nonexistent in 2012 to 2 percent in 2013.

Read more:

West News

Doctors Vow to Put Pinch on Rx Pills
Anna Bitong, The Acorn
February 12, 2015

Under a new policy, doctors in Ventura County, Calif.'s eight emergency rooms will prescribe limited amounts of pain relievers. They will not prescribe long-acting pain formulations or refill lost or stolen prescriptions. Doctors may also ask for a patient's photo identification before prescribing anything.

Read more:

Rx Drug Abuse Up 31 Percent in Utah; Campaign Aims to Get Rid of Unused Pills
Keith McCord, KSL
February 12, 2015

In Utah, more people die from prescription drug abuse than in car crashes. Prescription drug deaths rose 31 percent in the past 3 years. The state's Department of Health recently announced a campaign to encourage safe use, storage, and disposal of all prescription medications. Nearly 24 pharmacies across Utah have secure drop-off boxes. Pharmacies will put up signs and print messages on pharmacy receipts. (Includes video: 2:19 minutes)

Read more:

Prescription Drug Monitoring Program 2014 Statistics
State of South Dakota
February 10, 2015

South Dakota's prescription drug monitoring program continues to see more voluntary participation by physicians and pharmacists. Law enforcement must go through an application process to access the database. In 2014, they requested 499 profiles. The Division of Criminal Investigation said 18 percent of 2014 drug investigations were diversion cases.

Read more:

Massive Drug Investigation Triggers Call for New Laws
Julie Cornell, KETV
February 9, 2015

A 22-year-old's prescription drug overdose death triggered an investigation that resulted in federal drug convictions for 32 people. The father of the deceased, who took his son's case to the Nebraska State Patrol, urged lawmakers to create a mandatory-use prescription monitoring program. Currently, providers and patients can opt out of Nebraska's system. (Includes video: 5:41 minutes)

Read more:

Prescription Drug Monitoring Bill Wins Support in Oklahoma House
Rick Green, The Oklahoman
February 9, 2015

The Oklahoma House approved prescription monitoring program legislation and sent it to the Senate. This bill would require doctors to check the state database before prescribing addictive drugs.

Read more:

The Dangers of Driving Under the Influence of Prescription Drugs
Dennis Carlson, KPAX
February 12, 2015

Lewis and Clark County, Mont., is seeing more individuals driving under the influence of prescription drugs. The Deputy County Attorney prosecuted 15 to 20 cases in the past 2 years. This article offers three tips for driving safely while using medications.

Read more:

Patients Can Sue Drug Companies for Fraud, Arizona Court of Appeals Rules
Elizabeth Stuart, Phoenix New Times
February 6, 2015

The Arizona Court of Appeals unanimously ruled that people can sue pharmaceutical companies under the state's consumer fraud act. In a recent case, Amanda Watts alleged that Medicis Pharmaceutical Corporation failed to tell her about the long-term risks of Solodyn, an acne medication. In literature provided to the physician, Medicis warned "long term" use of minocycline may be connected to lupus-like symptoms and autoimmune hepatitis. However, the information provided to Watts made no such disclosure. She was hospitalized with drug-induced lupus and drug-induced hepatitis in late 2010.

Read more:

Other Resources

The Partnership for Drug-Free Kids Launches Interactive Tool to Illustrate How Pain Medicine Abuse Can Lead to Heroin Addiction
PR Newswire
February 12, 2015

The Partnership for Drug-Free Kids released an interactive infographic that illustrates the path leading teens and young adults from prescription pain reliever abuse to heroin addiction. The infographic follows the story of fictional teen Katie, who was prescribed pain relievers after sustaining an injury.

Read more:

Grant Announcements

Comparison and Validation of Screening Tools for Substance Use Among Pregnant Women
Centers for Disease Control and Prevention
Deadline: February 24, 2015

Prescription Monitoring Program Script Collection
Illinois Department of Human Services
Bid Date and Time: February 25, 2015, 2 p.m.

Strategic Prevention Framework Partnerships for Success: State and Tribal Initiative
Substance Abuse and Mental Health Services Administration
Deadline: March 16, 2015

Drug-Free Communities Support Program
Substance Abuse and Mental Health Services Administration
Deadline: March 18, 2015

Drug-Free Communities Mentoring Program
Substance Abuse and Mental Health Services Administration
Deadline: April 14, 2015

The Drug-Free Communities Mentoring Program assists newly forming coalitions in becoming eligible to apply for Drug-Free Communities funding.

Read more:

Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders
National Institutes of Health
Deadline: April 15, 2015

Take-Back Events and Drop Boxes

Prescription Take-Back Day March 21st
Chatham Habitat for Humanity (North Carolina)
February 10, 2015

Prescription Medication Take-Back Program a Success, Sheriff's Office Has Been Accepting Prescription Medicines Since August 2013
Theresa Marthey, The Preston County News and Journal (West Virginia)
February 11, 2015

Brick Middle School Students Help Police Collect Unused Prescription Drugs
Daniel Nee, Brick Shorebeat (New Jersey)
February 7, 2015

Medicine Drop Box in Place in Fair Lawn
Tracey Putrino, North Jersey Media Group
February 11, 2015

Drug Take-Back Planned for Southern York County
Sean Cotter, York Dispatch (Pennsylvania)
February 10, 2015

Jackson PD No Longer Accepting Prescriptions for Disposal
James Long, KFVS (Missouri)
February 11, 2015

Upcoming Conferences and Workshops

Collaborative Perspectives on Addiction 2015: 'Changing Landscapes of Addiction'
The Society of Addiction Psychology
March 6–7, 2015
Baltimore, Maryland

Pharmacy Diversion Awareness Conferences
Drug Enforcement Administration, Office of Diversion Control
March 28–29, 2015: Birmingham, Ala.
May 30–31, 2015: Norfolk, Va.
June 27–28, 2015: Oklahoma City, Okla.

2015 AATOD Conference—Address a Public Health Crisis: Opioid Dependence
American Association for Treatment of Opioid Dependence, Inc. (AATOD)
March 28–April 1, 2015
Atlanta, Georgia

National Rx Drug Abuse Summit
April 6–9, 2015
Atlanta, Georgia

48th Annual Communicating Nursing Research Conference—Equity and Access: Nursing Research, Practice, and Education
Western Institute of Nursing
April 22–25, 2015
Albuquerque, New Mexico

Fourth Annual Generation Rx University Conference for Collegiate Prevention and Recovery
Ohio State University College of Pharmacy
August 4–6, 2015
Columbus, Ohio

University of Michigan Injury Center Prescription Drug Overdose Summit
University of Michigan Injury Center
November 9, 2015
Ann Arbor, Michigan
The Weekly Update is a service provided by the SAMHSA Preventing Prescription Abuse in the Workplace Technical Assistance Center (PAW) to keep the field abreast of recent news and journal articles to assist in forming policy, research, and programs to reduce prescription drug misuse or abuse. Please note, the materials listed are not reflective of SAMHSA's or PAW's viewpoint or opinion and are not assessed for validity, reliability or quality. The Weekly Update should not be considered an endorsement of the findings. Readers are cautioned not to act on the results of single studies, but rather to seek bodies of evidence. Copyright considerations prevent PAW from providing full text of journal articles listed in the Weekly Update.